IMPACT TB
Tuberculosis kills 5,000 people every day and over 1,000 people fall sick with TB each hour. The great majority of these are the poorest members of our society, with limited access to healthcare and no resources to cope with illness. We know that for any infectious disease the best way to control epidemics is either through vaccines or finding and treating every case to prevent transmission. The only TB vaccine, BCG, is not very effective and this has allowed TB to continue to kill millions of people every year. IMPACT TB is a project to find and treat cases of…
read more
NEWS UPDATES
IMPACT TB represented at 2023 UNION Conference
Posted on: November 22, 2023
The 2023 Union World Conference on Lung Health took place in Paris from 15-18th November. As this was the first in-person Union event since the pandemic, it was a great opportunity for those work on the… Read More
2023 UNION CONFERENCE ON LUNG HEALTH: PREVIEW
Posted on: October 05, 2023
The 2023 Union World Conference on Lung Health will take place in Paris from 15-18th November. The conference theme, Transforming Evidence into Practice, explores the challenges facing global health research. Generating new evidence from research projects… Read More
Dr Maxine Caws visits New York as part of UN High Level meeting on TB
Posted on: September 25, 2023
The UN High Level meeting took place on 22nd September. IMPACT TB Principal Investigator, Dr Maxine Caws, was in New York to meet with a wide variety of TB stakeholders and attended numerous events related to… Read More
Our Team
Maxine Caws
(Liverpool School of Tropical Medicine)
Max Caws is the Principal Investigator of IMPACT TB and a senior TB researcher at the Liverpool School of Tropical Medicine. She was Head of the TB group at Oxford University Clinical Research Unit Vietnam for 11 years and researches diverse aspects of TB including drug resistance, diagnosis, clinical treatment trials, bacterial virulence and host susceptibility determinants. She is currently based in Kathmandu, Nepal. She has a BSc in biochemistry from the University of St Andrews, a PHD in medical microbiology from King’s College, London, where her thesis topic was tuberculous meningitis, and an MSC in epidemiology from the London School of Hygiene and Tropical…
Raghu Dhital
(Executive Director, Birat Nepal Medical Trust)
Raghu Dhital is the Executive Director of BNMT. He has been involved with Birat Nepal Medical Trust, Nepal since July 2014. His main responsibilities are to oversee the overall activities of BNMT; develop strategies, plans and activities for the all the programs of BNMT; establish good coordination and collaboration with government authorities, District Health Offices, NGO partners and advocates and facilitate the successful implementation of Tuberculosis Control Program. Before taking this role, Raghu served as the Deputy director of BNMT. He previously worked as Project Manager for IMPACT TB phase I from 2017-2019. He was involved in Britain Nepal Medical Trust as a TB REACH…
Kritika Dixit
(Research Manager, Birat Nepal Medical Trust)
Kritika Dixit is a Research Manager at BNMT with experience of over eight years in infectious diseases, mental health and reproductive and sexual health. Her main area of interest is the social and structural determinants of health and the design and evaluation of socioeconomic interventions to tackle these factors. Ms Dixit led research projects that mainly involve exploring barriers to healthcare access especially in rural areas and to provide evidence to inform patient-centric healthcare models to improve equity in communities. More recently, she led the research implementation in the projects supported by the European Union, the Wellcome Trust, UK, and the Stop TB partnership which…